Trial · NCT00471497
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Core Treatment Phase | STARTED | Imatinib 400 mg QD | 283 | |
| Core Treatment Phase | STARTED | Nilotinb 300 mg BID | 282 | |
| Core Treatment Phase | STARTED | Nilotinib 400 mg BID | 281 | |
| Core Treatment Phase | Safety Analysis Set | Imatinib 400 mg QD | 280 | |
| Core Treatment Phase | Safety Analysis Set | Nilotinb 300 mg BID | 279 | |
| Core Treatment Phase | Safety Analysis Set | Nilotinib 400 mg BID | 277 | |
| Core Treatment Phase | Discon. Core/Did Not Enter Ext. | Imatinib 400 mg QD | 235 | |
| Core Treatment Phase | Discon. Core/Did Not Enter Ext. | Nilotinb 300 mg BID | 256 | |
| Core Treatment Phase | Discon. Core/Did Not Enter Ext. | Nilotinib 400 mg BID | 278 | |
| Core Treatment Phase | Discontinued Core/Entered Ext. | Imatinib 400 mg QD | 48 | |
| Core Treatment Phase | Discontinued Core/Entered Ext. | Nilotinb 300 mg BID | 26 | |
| Core Treatment Phase | Discontinued Core/Entered Ext. | Nilotinib 400 mg BID | 3 | |
| Core Treatment Phase | COMPLETED | Imatinib 400 mg QD | 99 | |
| Core Treatment Phase | COMPLETED | Nilotinb 300 mg BID | 107 | |
| Core Treatment Phase | COMPLETED | Nilotinib 400 mg BID | 99 | |
| Core Treatment Phase | NOT COMPLETED | Imatinib 400 mg QD | 184 | |
| Core Treatment Phase | NOT COMPLETED | Nilotinb 300 mg BID | 175 | |
| Core Treatment Phase | NOT COMPLETED | Nilotinib 400 mg BID | 182 | |
| Extension Phase | STARTED | Imatinib 400 mg QD | 48 | |
| Extension Phase | STARTED | Nilotinb 300 mg BID | 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00471497/flow